Institutional Biosafety Committee at Brandeis University
Brandeis University has established an Institutional Biosafety Committee (IBC) to oversee the safe conduct of research involving human blood, fluids, tissues, and cell lines; infectious agents; select agents; and recombinant DNA technology. The committee ensures compliance with the National Institutes of Health (NIH) Guidelines and the Center for Disease Control and Prevention (CDC).
All faculty, staff, students or users of the facilities at Brandeis University who are contemplating use of recombinant DNA research must comply with these Guidelines. At Brandeis University, all protocols in which recombinant DNA or the other biohazardous materials listed above will be used, regardless of the funding source, must be submitted to the Institutional Biosafety Committee for review.
The IBC is composed of faculty investigators with expertise in rDNA and biohazard research, an environmental health and safety expert, an independent scientific consultant, an administrator, and members of the community.
To learn more about the IBC at Brandeis University, please navigate the IBC webpage using the links below.